A common question from manufacturers is whether production scale-up — moving from prototype or pilot production to full-scale production — can qualify as research and development for the federal R&D tax credit under Section 41. The short answer is that production scale-up may constitute qualified research when scaling involves a technical uncertainty about process capability or performance and a process of experimentation. Routine scale-up of a proven process generally is not qualified research, and the commercial-production boundary is a key consideration. This page explains the framework in general terms. It is educational and is not individualized advice. For the foundational framework, see our page on qualified research.
When Scale-Up May Warrant Review
Production scale-up may warrant review when scaling involves a genuine technical uncertainty about whether a process that worked at prototype or pilot scale can achieve a required performance at full scale, and a process of experimentation. Under the four-part test, the work must be for a permitted purpose (developing or improving a manufacturing process), be technological in nature, be intended to eliminate uncertainty, and be conducted through a process of experimentation.
Common scenarios that may warrant review include:
- Process instability at scale — evaluating alternative process parameters or equipment to resolve uncertainty about whether a process that was stable at pilot scale can maintain stability at full scale.
- Output and quality tradeoffs — testing alternative process configurations to resolve uncertainty about whether a scaled-up process can achieve the required output rate without sacrificing quality.
- Scaling formulations — evaluating alternative formulations or process conditions to resolve uncertainty about whether a formulation that worked at lab scale can be produced at production scale.
- Scaling processes — testing alternative process sequences or equipment configurations to resolve uncertainty about whether a process can achieve the required performance at a larger scale.
In each case, the question is whether the scaling work evaluates alternatives to resolve a technical uncertainty, not merely whether production was scaled.
The Commercial-Production Boundary
A key consideration for scale-up activities is the commercial-production boundary. Section 41 and the Treasury Regulations address research conducted after commercial production begins. Scale-up activities that occur before commercial production begins — during the development phase — are more likely to be part of qualified research, provided the other elements are met. Scale-up activities that occur after commercial production has begun may fall within the post-commercial-production exclusion.
The timing of when commercial production begins is a facts-and-circumstances determination. Generally, commercial production begins when the business component is ready for commercial sale or use. Scale-up activities that are part of the development of a new process — before the process is ready for commercial production — may warrant review. For more, see our page on research after commercial production.
Routine Scale-Up vs. Technical Development
A central distinction is between routine scale-up and technical development:
- Routine scale-up — scaling a proven process by adding capacity (more machines, larger batches, longer runs) where there is no technical uncertainty about whether the process will work at scale. This is capacity expansion, not research.
- Technical development — scaling a process where there is a technical uncertainty about whether the process can achieve a required performance at scale, and evaluating alternatives to resolve that uncertainty. This may warrant review as qualified research.
The distinction turns on whether there is a genuine technical uncertainty about scaling. A company that is simply adding more of the same equipment is generally not conducting research. A company that is resolving a technical uncertainty about whether a process can work at a new scale may be.
Hypothetical Example
Consider a manufacturer that has developed a new chemical process at pilot scale and is uncertain whether the process can achieve the required yield and purity at full production scale. The company evaluates alternative reactor configurations, tests different process parameters at intermediate scale, and systematically varies conditions to resolve the uncertainty before full-scale production begins. This systematic evaluation of alternatives to resolve a technical uncertainty about scale-up may warrant review as qualified research.
By contrast, if the same manufacturer simply adds a second production line identical to an existing proven line, that is capacity expansion, not research.
This example is illustrative only and does not state that the activity definitely qualifies.
Documentation That May Help
Records that can help support scale-up claims include scale-up plans identifying the uncertainty and alternative approaches, pilot and intermediate-scale test results, process-parameter data at each scale, records of how results informed process changes, and records showing when commercial production began. For more, see our page on R&D tax credit documentation.
Key Takeaway
Production scale-up activities may constitute qualified research when scaling involves a technical uncertainty about process capability or performance and a process of experimentation. Routine scale-up of a proven process generally is not qualified research, and the commercial-production boundary is a key consideration. Because the distinction is fact-specific, professional review is appropriate before claiming the credit.